<bill session="109" type="s" number="3695" updated="2013-07-19T20:45:37-04:00">
  <state datetime="2006-07-19">REFERRED</state>
  <status>
    <introduced datetime="2006-07-19"/>
  </status>
  <introduced datetime="2006-07-19"/>
  <titles>
    <title as="introduced" type="official">A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.</title>
  </titles>
  <sponsor id="300084"/>
  <cosponsors>
    <cosponsor id="300061" joined="2006-09-07"/>
    <cosponsor id="300065" joined="2006-07-19"/>
    <cosponsor id="300087" joined="2006-07-19"/>
  </cosponsors>
  <actions>
    <action datetime="2006-07-19">
      <text>Sponsor introductory remarks on measure.</text>
      <reference ref="CR S7927"/>
    </action>
    <action state="REFERRED" datetime="2006-07-19">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
      <reference ref="CR S7928" label="text of measure as introduced"/>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral, In Committee"/>
  </committees>
  <relatedbills>
    <bill relation="identical" session="109" type="h" number="5993"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Commerce"/>
    <term name="Drug approvals"/>
    <term name="Drug industry"/>
    <term name="Generic drugs"/>
  </subjects>
  <amendments/>
  <summary>7/19/2006--Introduced.
Amends the Federal Food, Drug, and Cosmetic Act to prohibit a holder of a new, approved drug application from manufacturing, marketing, selling, or distributing a generic version of such drug during any exclusivity period granted to manufacturers of generic brands.</summary>
</bill>
